2 results
Approved WMOCompleted
The objective of this study is to evaluate the safety and performance of the ROX Coupler in subjects with resistant hypertension.
Approved WMORecruiting
To determine the safety, feasibility, and tolerability of adding PIPAC with oxaliplatin (92 mg/m2) to systemic chemotherapy in patients with isolated PM from CRC.